These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

945 related articles for article (PubMed ID: 10919738)

  • 1. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
    Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
    Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR
    Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.
    Vrieling A; Buck K; Kaaks R; Chang-Claude J
    Breast Cancer Res Treat; 2010 Oct; 123(3):641-9. PubMed ID: 20711809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
    Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
    Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
    Nichols HB; Trentham-Dietz A; Love RR; Hampton JM; Hoang Anh PT; Allred DC; Mohsin SK; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy balance and breast cancer risk: a prospective cohort study.
    Silvera SA; Jain M; Howe GR; Miller AB; Rohan TE
    Breast Cancer Res Treat; 2006 May; 97(1):97-106. PubMed ID: 16319973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States).
    Li CI; Malone KE; Daling JR
    Cancer Causes Control; 2006 Jun; 17(5):695-703. PubMed ID: 16633917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
    Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status.
    Zhang M; Yang H; Holman CD
    Breast Cancer Res Treat; 2009 Dec; 118(3):553-63. PubMed ID: 19252980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors.
    Barnes BB; Steindorf K; Hein R; Flesch-Janys D; Chang-Claude J
    Cancer Epidemiol; 2011 Aug; 35(4):345-52. PubMed ID: 21159569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-life physical activity and postmenopausal breast cancer: effect of body size and weight change.
    Shoff SM; Newcomb PA; Trentham-Dietz A; Remington PL; Mittendorf R; Greenberg ER; Willett WC
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):591-5. PubMed ID: 10868694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of women with node negative breast cancer in the Auckland region.
    Lethaby AE; Mason BH; Harvey VJ; Holdaway IM
    N Z Med J; 1996 Sep; 109(1029):330-3. PubMed ID: 8862351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status.
    Rusiecki JA; Holford TR; Zahm SH; Zheng T
    Cancer Detect Prev; 2005; 29(5):419-26. PubMed ID: 16185815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
    Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers associated with breast cancer are associated with obesity.
    Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
    Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.